# Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B

> **NCT03050905** · PHASE4 · COMPLETED · sponsor: **HaEmek Medical Center, Israel** · enrollment: 7 (actual)

## Conditions studied

- HCV Coinfection

## Interventions

- **DRUG:** VEKIRAX
- **DRUG:** EXVIERA

## Key facts

- **NCT ID:** NCT03050905
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-22
- **Primary completion:** 2017-11-16
- **Final completion:** 2018-11-28
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2019-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03050905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03050905, "Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03050905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*